Shukra Pharmaceuticals has approved a proposal to change its name to Shukra Medtech Limited and expand its main business objectives to include the medical technology sector.

This strategic move aims to broaden the company's corporate identity and enable it to pursue new opportunities in MedTech, covering development, manufacturing, and distribution of products and solutions.

This expansion, pending necessary approvals, signals the company's intent to diversify and capitalize on the growing healthcare and medical technology ecosystem for sustainable long-term growth, which could enhance future business prospects.